Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COP9 signalosome subunit 9 is one of the components of the COP9 signalosome (CSN), an evolutionarily conserved eight-subunit protein complex found in all eukaryotes. The CSN complex is a master regulator of the ubiquitin-proteasome pathway, primarily by removing the ubiquitin-like protein NEDD8 from cullin subunits of cullin-RING ligases (CRLs). This deneddylation inactivates CRLs, thereby tightly controlling protein degradation and various cell signaling pathways. COPS9 is a structural component essential for the function and integrity of the CSN complex, which is involved in processes such as cell cycle regulation, response to DNA damage, cell proliferation, and transcriptional control. While the CSN as a whole is explored as a potential therapeutic target in cancer and other diseases, there is no evidence that COPS9 alone is the direct molecular target for any approved or experimental drugs[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COP9 signalosome subunit 9 (COPS9).